Kazia Therapeutics Income Statement (2009-2025) | KZIA

Income Statement Jun2009 Dec2009 Jun2010 Dec2010 Jun2011 Dec2011 Jun2012 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & cost
Revenue (Quarter)
Operating items
Depreciation & Amortization - Total (Quarter)
0.04M0.16M73.89
Wages, Salaries and Other (Quarter)
Share-based Compensation (IS) (Quarter)
Operating Expenses (Quarter)
0.04M0.16M73.89
EBIT (Quarter)
Non-operating items
Other Non Operating Income (Quarter)
0.74M
Net income details
EBT (Quarter)
Tax Provisions (Quarter)
Profit After Tax (Quarter)
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)
1.66M
Income from Continuing Operations (Quarter)
Consolidated Net Income (Quarter)
Income towards Parent Company (Quarter)
Net Income towards Common Stockholders (Quarter)
Additional items
EPS (Basic) (Quarter)
Shares Outstanding (Weighted Average) (Quarter)
0.00M319.16M-121.69M363.05M675.9836.65M26.29M43.55M44.74M62.00M52.91M101.66M99.39M59.36M65.13M0.00M219.36M16.0878.80M122.51M
Shares Outstanding (Diluted Average) (Quarter)
33.95M675.9844.74M78.52M0.01M0.00M0.00M
EBITDA (Quarter)
Interest Expenses (Quarter)
Shares Outstanding (Quarter)
36.65M43.55M62.00M101.66M99.39M152.41M219.36M518.38M
Tax Rate (Quarter)